A Study on Comparison of Efficacy Between Calfactant and Poractant Alfa In Extremely Premature Infants (<28 Weeks' Gestation) With Respiratory Distress Syndrome (PAS 2026) - Feb 25, 2026 - Abstract #1724.748; Pres time: Apr 24, 2026; 05:30 PM - 08:00 PM; Location: Poster Hall; "Among 63 eligible infants, 44 received CFT and 19 received PRT. Baseline characteristics (Table 1) were similar, except for higher out born status (42.1% vs. 11.4%, p=0.006) and lower antenatal steroid exposure (52.6% vs."
Clinical • Acute Respiratory Distress Syndrome • Bronchopulmonary Dysplasia • Cardiovascular • Hematological Disorders • Pulmonary Arterial Hypertension • Respiratory Diseases
|
|
Jay Pandya; Hannah Austin; Makayla Bresnock; Padma Nandula; Vasantha HS. Kumar; Sanket Shah
|